Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).

CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.

The drugmaker did not immediately comment on the matter.

Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.

          
Must Read
Image
Only biological and not trans women meet definition of woman, UK’s top court rules
April, 16 2025
Image
Trump tariffs: Apple airlifts iPhones worth a record $2 billion from India
April, 15 2025
Image
Saudi Arabia plans to pay off Syria’s World Bank debts
April, 14 2025
Image
China builds World’s highest bridge, cutting travel time to one minute
April, 14 2025